A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
Authors
Keywords
Early stage breast cancer, Brest cancer stem cell, Relapse risk score, Prognosis
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-24
DOI
10.1186/s12885-019-5941-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
- (2017) Feng Ye et al. Journal of Breast Cancer
- Prevalence of protein C receptor (PROCR) is associated with inferior clinical outcome in Breast invasive ductal carcinoma
- (2017) Qiu Yan et al. PATHOLOGY RESEARCH AND PRACTICE
- A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning
- (2017) Mohammad R. Mohebian et al. Computational and Structural Biotechnology Journal
- Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
- (2016) An Na Seo et al. BRITISH JOURNAL OF CANCER
- Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
- (2016) Fang Yang et al. International Journal of Biological Sciences
- Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
- (2015) M. Gnant et al. ANNALS OF ONCOLOGY
- Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast
- (2015) Ming Liang Oon et al. BREAST CANCER RESEARCH AND TREATMENT
- Whose Disease Will Recur After Mastectomy for Early Stage, Node-Negative Breast Cancer? A Systematic Review
- (2015) Collin Kent et al. Clinical Breast Cancer
- The relevance of EMT in breast cancer metastasis: Correlation or causality?
- (2015) Ruben Bill et al. FEBS LETTERS
- Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States
- (2015) Javaid Iqbal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Presence of EpCAM-/CD49f+Cells in Breast Cancer Is Associated with a Poor Clinical Outcome
- (2015) Feng Ye et al. Journal of Breast Cancer
- New Findings on Breast Cancer Stem Cells: A Review
- (2015) Azam Bozorgi et al. Journal of Breast Cancer
- A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients
- (2015) Jie Sun et al. Scientific Reports
- Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule
- (2015) Gabriella Honeth et al. Stem Cell Reports
- Breast cancer stem cells: Multiple capacities in tumor metastasis
- (2014) Shao-Qing Geng et al. CANCER LETTERS
- The mammary cellular hierarchy and breast cancer
- (2014) Samantha R. Oakes et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
- (2014) Yan Qiu et al. Journal of Breast Cancer
- Identification of multipotent mammary stem cells by protein C receptor expression
- (2014) Daisong Wang et al. NATURE
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- Concise Review: Breast Cancer Stem Cells: Regulatory Networks, Stem Cell Niches, and Disease Relevance
- (2014) Wenjun Guo Stem Cells Translational Medicine
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
- (2013) Hazem Ghebeh et al. BMC CANCER
- Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm
- (2013) Ferdinando Mannello BMC Medicine
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- Breast cancer stem cells: an update
- (2013) Jabed Iqbal et al. JOURNAL OF CLINICAL PATHOLOGY
- Breast cancer stem cells: Obstacles to therapy
- (2012) Matthew Smalley et al. CANCER LETTERS
- Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
- (2012) A. Giordano et al. MOLECULAR CANCER THERAPEUTICS
- The protein C pathway in cancer metastasis
- (2012) C. Arnold Spek et al. THROMBOSIS RESEARCH
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy
- (2011) Ciara S. O’Brien et al. Hormones & Cancer
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
- (2009) Ciara S. O’Brien et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now